Tube Formation Potential of BMSCs and USSCs in Response to HIF-1α Overexpression under Hypoxia


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Despite numerous studies on therapeutic effects of mesenchymal stem cells on ischemic tissue regeneration, including angiogenesis, their mechanism of action remains ambiguous. Due to the scarce of investigations based on different stem cell sources with known inherent molecular differences, present study compare tube formation of Bone marrow Mesenchymal Stem Cells and Unrestricted Somatic Stem Cells with known reported different Hox gene expression profile in response to HIF-1α overexpression under hypoxia. This might shed light on some parameters for selection of more responsive source with improved therapeutic effects. Superior in vitro tube formation on Matrigel substratum has been observed by Unrestricted Somatic Stem Cells compared to Bone marrow Mesenchymal Stem Cells which might possibly be due to the discriminating molecular properties of stem cell sources. It may help choosing the appropriate stem cell type for a given therapeutic expectations and also suggests some potential targets for future genetic modification of stem cells.

Sobre autores

V. Razban

Department of Molecular Medicine, School of Advanced Medical Sciences and Technologies; Stem Cell Technology Research Center

Autor responsável pela correspondência
Email: razban_vahid@yahoo.com
Irã, Shiraz; Shiraz

S. Khajeh

Department of Biochemistry, School of Medicine

Email: razban_vahid@yahoo.com
Irã, Shiraz

S. Alaee

Department of Reproductive Biology, School of Advanced Medical Sciences and Technologies

Email: razban_vahid@yahoo.com
Irã, Shiraz

Z. Mostafavi-Pour

Department of Biochemistry, School of Medicine

Email: razban_vahid@yahoo.com
Irã, Shiraz

M. Soleimani

Department of Hematology, Faculty of Medicine

Email: razban_vahid@yahoo.com
Irã, Tehran


Declaração de direitos autorais © Allerton Press, Inc., 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies